This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sugiura, Y. Articles by DeClerck, Y. A. Search for Related Content PubMed PubMed Citation Articles by Sugiura, Y. Articles by DeClerck, Y. A.

The Plasminogen-Plasminogen Activator (PA) System in Neuroblastoma

Role of PA Inhibitor-1 in Metastasis¹

Division of Hematology-Oncology, Department of Pediatrics [Y. S., L. M., B. S., W. E. L., R. C. S., Y. A. D.], Department of Pathology [H. S.], and Department of Biochemistry and Molecular Biology [Y. A. D.], Children’s Hospital Los Angeles, and University of Southern California, Los Angeles, California 90027

ABSTRACT

Proteases of the plasminogen-plasminogen activator (PA) system play an important role in cancer metastasis. We have examined the expression of these proteases and their cell surface receptors and inhibitors in neuroblastoma, a tumor that originates in cells of the neural crest and is the second most common solid tumor in children. This analysis was performed in seven established human cell lines and 20 primary tumor specimens. Urokinase PA and, in particular, tissue-type PA were expressed in cell lines and in tumor tissues; however, their levels of expression did not correlate with clinical stage. There was little evidence suggesting that neuroblastoma cells concentrate PA activity at their cell surface because urokinase-type PA receptor mRNA was detected in two cell lines and in 5 of 20 tumor samples by reverse transcription-PCR only. PA inhibitor (PAI)-2 was absent in all cell lines and tumor tissue samples examined. However, PAI-1, which was not expressed by the cell lines, was expressed by stromal cells and, specifically, endothelial cells in tumor tissue. By extending the analysis of PAI-1 expression in 64 primary tumor specimens, we found that high PAI-1 expression paradoxically correlated with metastatic stage and tumor recurrence. In vitro experiments indicated that the expression of PAI-1 by human microvascular endothelial cells was stimulated in the presence of SK-N-BE(2) human neuroblastoma cells and neuroblastoma culture medium. Recombinant PAI-1 also promoted SK-N-BE(2) cell detachment from vitronectin and migration from vitronectin toward fibronectin. From these data, we conclude that the up-regulation of PAI-1 expression in endothelial cells may promote rather than inhibit metastasis in neuroblastoma.

This article has been cited by other articles:

				Y. Fukaya, H. Shimada, L.-C. Wang, E. Zandi, and Y. A. DeClerck Identification of Galectin-3-binding Protein as a Factor Secreted by Tumor Cells That Stimulates Interleukin-6 Expression in the Bone Marrow Stroma J. Biol. Chem., July 4, 2008; 283(27): 18573 - 18581. [Abstract] [Full Text] [PDF]

				M.-T. Lin, I-H. Kuo, C.-C. Chang, C.-Y. Chu, H.-Y. Chen, B.-R. Lin, M. Sureshbabu, H.-J. Shih, and M.-L. Kuo Involvement of Hypoxia-inducing Factor-1{alpha}-dependent Plasminogen Activator Inhibitor-1 Up-regulation in Cyr61/CCN1-induced Gastric Cancer Cell Invasion J. Biol. Chem., June 6, 2008; 283(23): 15807 - 15815. [Abstract] [Full Text] [PDF]

				E. Ortiz-Zapater, S. Peiro, O. Roda, J. M. Corominas, S. Aguilar, C. Ampurdanes, F. X. Real, and P. Navarro Tissue Plasminogen Activator Induces Pancreatic Cancer Cell Proliferation by a Non-Catalytic Mechanism That Requires Extracellular Signal-Regulated Kinase 1/2 Activation through Epidermal Growth Factor Receptor and Annexin A2 Am. J. Pathol., May 1, 2007; 170(5): 1573 - 1584. [Abstract] [Full Text] [PDF]

				Y. Chen, R. C. Budd, R. J. Kelm Jr, B. E. Sobel, and D. J. Schneider Augmentation of Proliferation of Vascular Smooth Muscle Cells by Plasminogen Activator Inhibitor Type 1 Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1777 - 1783. [Abstract] [Full Text] [PDF]

				M. Hecht, M. Papoutsi, H. D. Tran, J. Wilting, and L. Schweigerer Hepatocyte Growth Factor/c-Met Signaling Promotes the Progression of Experimental Human Neuroblastomas Cancer Res., September 1, 2004; 64(17): 6109 - 6118. [Abstract] [Full Text] [PDF]

				S. K. Thomas, C. A. Messam, B. A. Spengler, J. L. Biedler, and R. A. Ross Nestin Is a Potential Mediator of Malignancy in Human Neuroblastoma Cells J. Biol. Chem., July 2, 2004; 279(27): 27994 - 27999. [Abstract] [Full Text] [PDF]

				V M Diaz, M Hurtado, T M Thomson, J Reventos, and R Paciucci Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro Gut, July 1, 2004; 53(7): 993 - 1000. [Abstract] [Full Text] [PDF]

				H. Biliran Jr. and S. Sheng Pleiotrophic Inhibition of Pericellular Urokinase-type Plasminogen Activator System by Endogenous Tumor Suppressive Maspin Cancer Res., December 1, 2001; 61(24): 8676 - 8682. [Abstract] [Full Text] [PDF]

				C. Isogai, W. E. Laug, H. Shimada, P. J. Declerck, M. F. Stins, D. L. Durden, A. Erdreich-Epstein, and Y. A. DeClerck Plasminogen Activator Inhibitor-1 Promotes Angiogenesis by Stimulating Endothelial Cell Migration toward Fibronectin Cancer Res., July 1, 2001; 61(14): 5587 - 5594. [Abstract] [Full Text] [PDF]

				C. N. Rao, S. S. Lakka, Y. Kin, S. D. Konduri, G. N. Fuller, S. Mohanam, and J. S. Rao Expression of Tissue Factor Pathway Inhibitor 2 Inversely Correlates during the Progression of Human Gliomas Clin. Cancer Res., March 1, 2001; 7(3): 570 - 576. [Abstract] [Full Text]

				T.-H. Ngo, M. F. Hoylaerts, I. Knockaert, E. Brouwers, and P. J. Declerck Identification of a Target Site in Plasminogen Activator Inhibitor-1 That Allows Neutralization of Its Inhibitory Properties Concomitant with an Allosteric Up-regulation of Its Antiadhesive Properties J. Biol. Chem., July 6, 2001; 276(28): 26243 - 26248. [Abstract] [Full Text] [PDF]